A
Autolus Therapeutics plc (AUTL)
NMS – Real vaqt narxi. Valyuta: USD
1.60
+0.02 (1.27%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.66
+0.06 (3.75%)
Bozor oldidan: May 13, 2026, 5:24 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
1.60
+0.02 (1.27%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.66
+0.06 (3.75%)
Bozor oldidan: May 13, 2026, 5:24 AM EDT
Autolus Therapeutics plc, klinik bosqichdagi biofarmatsevtika kompaniyasi, Buyuk Britaniyada va xalqaro miqyosda saraton va otoimmün kasalliklarni davolash uchun T hujayrali terapiyalarni ishlab chiqadi. Kompaniya AUCATZYLni taklif etadi, bu lentivirusli vektor bilan transdutsiyalangan autolog T hujayralaridan iborat gen terapiyasi mahsuloti bo'lib, yangi anti-CD19 ximerik antigen retseptorini ifoda etadi. Shuningdek, u tizimli qizil volchanka, progressiv ko'p skleroz, B-NHL va CLL, hamda CNS limfomasini davolash uchun 1-bosqichda bo'lgan obe-celni; pediatrik B-ALL va volchanka nefritini davolash uchun 2-bosqichda bo'lgan obe-celni; pediatrik B-ALLni davolash uchun 1-bosqichda bo'lgan AUTO1/22ni; ko'p miyeloma va engil zanjirli amiloidozni davolash uchun 1-bosqichda bo'lgan AUTO8ni; periferik TCLni davolash uchun preklinik bosqichda bo'lgan AUTO4/5ni; neyroblastomani davolash uchun 1-bosqichda bo'lgan AUTO6NGni; va o'tkir miyeloid leykemiyani davolash uchun preklinik bosqichda bo'lgan AUTO9ni ishlab chiqadi. Kompaniya 2014 yilda tashkil etilgan va Buyuk Britaniyaning London shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Christian Martin Itin Ph.D. | CEO & Director |
| Dr. Christopher Williams Ph.D. | Senior VP & Chief Business Development Officer |
| Dr. Martin Pule M.D., MBBS | Founder, Senior VP & Chief Scientific Officer |
| Dr. Matthias Will M.D. | Senior VP & Chief Development Officer |
| Mr. Alex Driggs | Senior VP of Legal Affairs & General Counsel and Secretary |
| Mr. Alexander Swan | Senior VP & Chief Human Resources Officer |
| Mr. Christopher Vann | Senior VP & COO |
| Mr. Patrick McIlvenny | Senior VP of Finance, Chief Accounting Officer & Principal Accounting Officer |
| Mr. Robert F. Dolski | Senior VP & CFO |
| Ms. Miranda Neville | Senior VP & Chief Technology Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-29 | 8-K | d113906d8k.htm |
| 2026-04-16 | 8-K | autl-20260414.htm |
| 2026-04-15 | DEL AM | d132407ddelam.htm |
| 2026-04-13 | S-3 | d132407ds3.htm |
| 2026-04-08 | 8-K | autl-20260408.htm |
| 2026-03-27 | 8-K | autl-20260327.htm |
| 2026-03-27 | 10-K | autl-20251231.htm |
| 2025-12-02 | 8-K | autl-20251201.htm |
| 2025-11-18 | S-8 | d813559ds8.htm |
| 2025-11-12 | 8-K | autl-20251112.htm |